The effects of propranolol, 0.1 mg/kg given intravenously, on atrioventricular (A-V) conduction and intraventricular (IV) conduction were studied in eight patients. Atrial pacing was used to control the heart rate. His bundle electrograms were recorded, and the interval from the pacing impulse to the His bundle electrogram (P-H interval}. was used as a measure of A-V conduction and the interval from the His bundle electrogram to the S wave (H-S interval) was used as a measure of intraventricular conduction. Propranolol significantly prolonged the P-H interval in every patient at all paced heart rates, and it had no effect on the H-S interval. In two patients propranolol prolonged the effective refractory period of the atrioventricular conducting tissue.
to produce beta-adrenergic blockade or to a nonspecific action .7 In this investigation the technic of recording His bundle electrograms8 was used to study the effects of propranolol on cardiac conduction in man. In addition, the effects of propranolol on intraventricular conduction were studied in six dogs during His bundle pacing.9
Methods

Human Studies
Right heart catheterization was performed on, eight patients who were in a postabsorptive, nonsedated state. All patients were informed of the nature of the study and a signed consent was obtained. All subjects were in sinus rhythm with-a P-R interval of less than 200 msec. Two of the eight patients had multifocal premature ventricular contractions (PVCs). None of the patients had a history of congestive heart failure or bronchospasm and none were taking cardiotonic drugs. Under There were no untoward side effects from the intravenous administration of propranolol. The blood pressure remained stable in all patients. The average systolic blood pressure was 4.6 mm Hg lower after injection of the drug.
Propranolol prolonged the P-H interval in every patient at all paced heart rates (table 1). The control values of the P-H intervals in the eight patients at paced heart rates of 100, 120, and 140 beats/min averaged 169, 186, and 202 msec, respectively. After the administration of propranolol the P-H intervals averaged 188, 207, and 230 msec. These changes represent a significant prolongation of the P-H interval at all paced rates. Propranolol did not prolong the H-S interval in any of the eight patients. A representative recording is presented in figure 1 . During atrial pacing at a rate of 120/min, the P-H, H-Q, and H-S intervals were 186, 62, and 142 msec. After the administration of propranolol the P-H interval was prolonged to 212 msec, but the H-Q and H-S intervals were unchanged. Figure 2 illustrates the effects of propranolol on the effective refractory period (ERP) of atrioventricular conducting tissue. In the control state (top panel) a premature atrial depolarization (P') is followed by propagated ventricular response. It should be noted that the P-H and H-S intervals of the premature beat are longer than those of the regular sinus beat. Thus conduction was slowed proximal and distal to the His bundle, presumably in the A-V node and in the specialized conducting tissue of the ventricle. The premature impulse was brought in closer to the sinus beat, and at a P-P' interval of 380 msec no propagated ventricular response followed the atrial depolarization (middle panel, fig. 2 ). The absence of a His deflection following the The effect of propranolol, 0.1 mg/kg iv, on the P-H, H-Q, and H-S intervals during atrial pacing at a rate of 120/min. In the control recording the P-H interval was 186 msec. Propranolol prolonged the P-H interval to 212 msec. The H-Q and H-S intervals remained the same (62 and 142 msec, respectively). PI denotes the pacer impulse. P The effects of propranolol on the effective refractory period (ERP) of atrioventricular conducting tissue. In the control state (top panel) at a P-P' interval of 430 msec, the P' is conducted aberrantly, and the P-H and H-Q intervals are prolonged. figure 2 , where the premature atrial depolarization (P') is not followed by a propagated ventricular response. In the other patient studied propranolol prolonged the ERP of the atrioventricular conducting tissue from 320 to 360 msec.
In both patients with VPCs propranolol had no effect on the arrhythmia. However, prior to the administration of the drug, the VPCs were suppressed at atrial pacing rates of 120/min in both patients, whereas after administration of propranolol the VPCs were suppressed at an atrial pacing rate of 100/min as illustrated in figure 3 . In the top panel multifocal VPCs are evident during atrial pacing at a rate of 100/min. Parenthetically, it should be noted that each VPC is preceded by a P wave. There is an H spike, partially obscured by a time line, associated with the first VPC. However, the upstroke of the aberrant QRS complex occurs prior to the H spike. Therefore 
The effects of propranolol on PVCs during atrial pacing at a rate of 100/min. During the control state PVCs are evident. After the administration of propranolol no PVCs are present. Abbreviations are the same as in figure 1 . PVCs = premature ventricular contractions.
(lower panel) there were no VPCs at an atrial rate of 100/min.
Dog Studies
Although propranolol was administered to six dogs in a dosage 40 times greater than that used clinically, it had no significant effect on intraventricular conduction. In four dogs the average control H-S interval during His bundle pacing was 71 msec, and after propranolol (4 mg/kg iv) it remained 71 msec. In two dogs with prolonged H-S intervals secondary to toxic doses of ouabain and procainamide, propranolol again had no effect on the H-S interval. A representative experiment is shown in figure 4 . This dog had developed ventricular tachyeardia due to a toxic dose of ouabain. The arrhythmia was abolished by overdriving the ventricle with His bundle pacing at a rate of 210/min, and the H-S interval as measured from the pacing spike to termination of the QRS complex was 61 msec. Procainamide, 30 mg/kg iv, failed to abolish the ventricular tachycardia, and during His bundle pacing at a rate of 210/min, the H-S interval widened to 77 msec. Subsequent administration of propranolol termiCirculation, Volume XL, December 1969 nated the arrhythmia, and there was no further prolongation of the H-S interval; it remained 77 msec. Discussion The present study demonstrates that when propranolol is administered during fixed-rate atrial pacing it prolongs atrioventricular (A-V) conduction without affecting intraventricular conduction. However, when the drug is used clinically, its ability to slow the sinus rate indirectly enhances A-V conduction, since A-V conduction time is shorter at a slower heart rate.'0'11 These two effects of the drug may counteract one another as illustrated in figure   2 . In the upper two panels at a sinus rate of 67/min the P-H interval was 105 msec. After the administration of propranolol the sinus rate fell to 55/min, but the P-H interval remained 105 msec. Similarly, Stem and Eisenberg'2 reported that propranolol prolonged the P-R interval in only 12 of 21 patients. In contrast in this study during fixed-rate atrial pacing propranolol prolonged A-V conduction in all patients.
It has been shown in the experimental animal that stellate stimulation'3 or the The effects of procainamide and propranolol on the H-S interval in a dog with digitalis toxicity This dog had digitalis-induced ventricular tachycardia that was overdriven by His bundle pacitng at a rate of 210/min (control record-top panel). The H-S interval, as measured from the His bundle-pacing impulse (labeled P.I.) to the S wave of the ECG, was 61 msec. Procainamide, 30 mg/kg iv, prolonged the H-S interval to 77 msec. Subsequent administration of propranolol, 30 mg/kg iv. had no effect on the H-S interval; it remained 77 msec. See text for further details.
administration of catecholamines14 shortens A-V conduction. Using the technic of recording His bundle electrograms in man, we have noted that isoproterenol shortens the P-H interval but has no effect on the H-S interval.'1 Thus propranolol's prolongation of the P-H interval and lack of effect on the H-S interval can be explained on the basis of its capacity to produce beta-adrenergic blockade. Conduction velocity is related to the rate of rise of the cardiac action potential (the dv/dt of phase 0) 18 Davis and Temte'5 found that propranolol depressed the dv/dt of phase 0 of the transmembrane action potential of Purkinje and ventricular muscle fibers of dogs. However, this effect of the drug in contrast to its effects on phases 2 and 3 of the transmembrane action potential only occurred at higher dosage levels in the tissue bath. Therefore, it is of interest in this study that when propranolol was administered in doses 30 to 40 times greater than that used clinically, it had no effect on intraventricular conduction in dogs with normal conducting systems and in dogs with conducting systems stressed by toxic doses of ouabain and procainamide.
Previously, Rouse19 had reported that propranolol in a dose of 5 mg/kg iv had no effect on the H-S interval in one animal.
Propranolol differs from quinidine and procainamide in that it does not prolong 
